Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kerstin Rönsch"'
Autor:
Rami Mäkelä, Antti Arjonen, Ville Härmä, Nina Rintanen, Lauri Paasonen, Tobias Paprotka, Kerstin Rönsch, Teijo Kuopio, Juha Kononen, Juha K. Rantala
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Ex vivo drug screening refers to the out-of-body assessment of drug efficacy in patient derived vital tumor cells. The purpose of these methods is to enable functional testing of patient specific efficacy of anti-cancer therapeuti
Externí odkaz:
https://doaj.org/article/57759f08eeff444d9a1a852ab997f3b4
Autor:
Marianna Alunni-Fabbroni, Kerstin Rönsch, Thomas Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-15 (2019)
Abstract Background Liquid biopsy based on cell-free DNA circulating in plasma has shown solid results as a non-invasive biomarker. In the present study we evaluated the utility of circulating free DNA (cfDNA) and the sub-type tumor DNA (ctDNA) in he
Externí odkaz:
https://doaj.org/article/c1825c1ef0f2494784138247015bb147
Autor:
Stefanie Dukowic-Schulze, Wilko Thiele, Boyan K. Garvalov, Amelia Foss, Jochen Utikal, Melanie Rothley, Nicole Grau, Sabine Wallbaum, Lenka Kyjacova, Natascha Cremers, Antje Neeb, Sandra D. Scherer, Norbert Gretz, Jonathan P. Sleeman, Rafael Saup, Sonja Thaler, Carsten Sticht, Kerstin Rönsch
Publikováno v:
Oncogene
Expression of the immediate-early response gene IER2 has been associated with the progression of several types of cancer, but its functional role is poorly understood. We found that increased IER2 expression in human melanoma is associated with short
Autor:
Max Seidensticker, Bristi Basu, Julia Mayerle, Chris Verslype, Marianna Alunni-Fabbroni, Peter Malfertheiner, Maciej Pech, Clemens C. Cyran, Kerstin Rönsch, Julia Benckert, Jens Ricke, Thomas Huber
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-15 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
BackgroundLiquid biopsy based on cell-free DNA circulating in plasma has shown solid results as a non-invasive biomarker. In the present study we evaluated the utility of circulating free DNA (cfDNA) and the sub-type tumor DNA (ctDNA) in hepatocellul
Autor:
Ville Härmä, Nina Rintanen, Tobias Paprotka, Lauri Paasonen, Antti Arjonen, Kerstin Rönsch, Teijo Kuopio, Rami Mäkelä, Juha Rantala, Juha Kononen
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Background Ex vivo drug screening refers to the out-of-body assessment of drug efficacy in patient derived vital tumor cells. The purpose of these methods is to enable functional testing of patient specific efficacy of anti-cancer therapeutics and pe
Autor:
Afsheen Yousaf, Silke Lassmann, Katja Rose, Maximilian Seidl, Roland Schüle, Sabine Jägle, Kerstin Rönsch, Tom Michoel, Francis Baumgartner, Vivien Freihen, Andreas Hecht, Robert Zeiser, Eric Metzger
Publikováno v:
Molecular Oncology. 9:335-354
EPHB3 is a critical cellular guidance factor in the intestinal epithelium and an important tumor suppressor in colorectal cancer (CRC) whose expression is frequently lost at the adenoma‐carcinoma transition when tumor cells become invasive. The mol
Autor:
Sabine Jägle, Silke Lassmann, Kerstin Rönsch, Monika Schrempp, Hana Andrlová, Afsheen Yousaf, Robert Zeiser, Sylvia Timme, Miriam Bertrand, Martin Werner, Amelie Proske, Tom Michoel, Andreas Hecht, Marcel Jäger
The protein tyrosine kinase Ephrin type-B receptor 3 (EPHB3) counteracts tumor-cell dissemination by regulating intercellular adhesion and repulsion and acts as tumor/invasion suppressor in colorectal cancer. This protective mechanism frequently coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7866e9ee54507fe0baf52f39bf6696
https://europepmc.org/articles/PMC3977263/
https://europepmc.org/articles/PMC3977263/
Publikováno v:
Epigenetics. 6(5)
Aberrant Wnt/β-catenin signaling is a driving force during initiation and progression of colorectal cancer. Yet, the Wnt/β-catenin targets CDX1, EPHB2, EPHB3 and EPHB4 (EPHB2-4) act as tumor suppressors in intestinal epithelial cells and frequently
Autor:
Kerstin Rönsch
Publikováno v:
Sicherheit und Freiheit statt Terror und Angst: Perspektiven einer demokratischen Sicherheit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3601fbeede4d0027c38e42e05aeb756d
https://doi.org/10.5771/9783845222806-69
https://doi.org/10.5771/9783845222806-69